Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VII

被引：19
|
作者：
Dargaud, Yesim [1 ]
Bordet, Jean-Claude [2 ]
Lienhart, Anne
Negrier, Claude
机构：
[1] Univ Hemostase Angiologue, Unite Hemostase Clin, Hop Edouard Herriot, F-69003 Lyon, France
[2] Hop Edouard Herriot, Hemostasis Lab, Lyon, France
来源：
SEMINARS IN HEMATOLOGY | 2008年 / 45卷 / 02期
关键词：
D O I：
10.1053/j.seminhematol.2008.03.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S72 / S73
页数：2
相关论文
共 50 条
  • [41] A response to 'The use of recombinant activated Factor VII in the control of haemorrhage following blunt pelvic trauma'
    Geoghegan, J
    Tasker, L
    ANAESTHESIA, 2005, 60 (11) : 1156 - 1157
  • [42] Activated recombinant factor VII (rFVIIa)
    Grottke, Oliver
    Henzler, Dietrich
    Rossaint, Rolf
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2010, 24 (01) : 95 - 106
  • [43] Recombinant activated factor VII and the anaesthetist
    Welsby, IJ
    Monroe, DM
    Lawson, JH
    Hoffmann, M
    ANAESTHESIA, 2005, 60 (12) : 1203 - 1212
  • [44] Standardization of factor VII/activated factor VII measurement in plasma of patients treated with recombinant factor activated VII
    Goudemand, J
    Caron, C
    Dreyfus, M
    Sié, P
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (05) : 505 - 511
  • [45] Successful use of recombinant activated factor VII in the treatment of vitreous haemorrhage: a report of seven cases
    Alameri, A
    Baker, NS
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (08) : 573 - 578
  • [46] Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding
    Vanek, T
    Straka, Z
    Hrabak, J
    Jares, M
    Brucek, PJ
    Votava, J
    JAPANESE HEART JOURNAL, 2004, 45 (05): : 855 - 860
  • [47] Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
    Jean-Louis Vincent
    Rolf Rossaint
    Bruno Riou
    Yves Ozier
    David Zideman
    Donat R Spahn
    Critical Care, 10
  • [48] Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective
    Vincent, Jean-Louis
    Rossaint, Rolf
    Riou, Bruno
    Ozier, Yves
    Zideman, David
    Spahn, Donat R.
    CRITICAL CARE, 2006, 10 (04)
  • [49] Recombinant activated factor VII (rVIIa): Predicting response in intractable bleeding
    Miall, FM
    Barton, LM
    Ayyash, R
    Tadd, SE
    Pavord, SR
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 20 - 20
  • [50] Recombinant Activated Factor VII-"Lifesaving or Surgeon Correcting"? Response
    Hauser, Carl J.
    Dutton, Richard
    Boffard, Kenneth D.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2011, 70 (02): : 524 - 525
12345